The Clinical Impact of Methotrexate-Induced Stroke-Like Neurotoxicity in Paediatric Departments: An Italian Multi-Centre Case-Series

Author:

Santangelo Andrea,Bartolini Emanuele,Nuzzi Giulia,Foiadelli Thomas,Michev Alexandre,Mina Tommaso,Trambusti Irene,Fichera Valeria,Bonuccelli Alice,Massimetti Gabriele,Peroni Diego G.,De Marco Emanuela,Coccoli Luca,Luti Laura,Bernasconi Sayla,Nardi Margherita,Menconi Maria Cristina,Casazza Gabriella,Pruna Dario,Mura Rosamaria,Marra Chiara,Zama Daniele,Striano Pasquale,Cordelli Duccio M.,Battini Roberta,Orsini Alessandro

Abstract

IntroductionStroke-like syndrome (SLS) is a rare subacute neurological complication of intrathecal or high-dose (≥500 mg) Methotrexate (MTX) administration. Its clinical features, evoking acute cerebral ischaemia with fluctuating course symptoms and a possible spontaneous resolution, have elicited interest among the scientific community. However, many issues are still open on the underlying pathogenesis, clinical, and therapeutic management and long-term outcome.Materials and MethodsWe retrospectively analyzed clinical, radiological and laboratory records of all patients diagnosed with SLS between 2011 and 2021 at 4 National referral centers for Pediatric Onco-Hematology. Patients with a latency period that was longer than 3 weeks between the last MTX administration of MTX and SLS onset were excluded from the analysis, as were those with unclear etiologies. We assessed symptom severity using a dedicated arbitrary scoring system. Eleven patients were included in the study.ResultsThe underlying disease was acute lymphoblastic leukemia type B in 10/11 patients, while fibroblastic osteosarcoma was present in a single subject. The median age at diagnosis was 11 years (range 4–34), and 64% of the patients were women. Symptoms occurred after a mean of 9.45 days (± 0.75) since the last MTX administration and lasted between 1 and 96 h. Clinical features included hemiplegia and/or cranial nerves palsy, paraesthesia, movement or speech disorders, and seizure. All patients underwent neuroimaging studies (CT and/or MRI) and EEG. The scoring system revealed an average of 4.9 points (± 2.3), with a median of 5 points (maximum 20 points). We detected a linear correlation between the severity of the disease and age in male patients.ConclusionsSLS is a rare, well-characterized complication of MTX administration. Despite the small sample, we have been able to confirm some of the previous findings in literature. We also identified a linear correlation between age and severity of the disease, which could improve the future clinical management.

Publisher

Frontiers Media SA

Subject

Neurology (clinical),Neurology

Reference36 articles.

1. Transient cerebral dysfunction secondary to high-dose methotrexate;Walker;J Clin Oncol.,1986

2. Hemiparesis and ischemic changes of the white matter after intrathecal therapy for children with acute lymphocytic leukemia;Yim;Cancer.,1991

3. Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemia;Rubnitz;Leukemia.,1998

4. Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome;Rollins;Am J Neuroradiol.,2004

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3